These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4422945)

  • 1. Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.
    Lowder SC; Liddle GW
    N Engl J Med; 1974 Dec; 291(23):1243-4. PubMed ID: 4422945
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
    Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
    Pessina AC; Corgnati A; Palù CD
    Minerva Med; 1977 Feb; 68(8):509-14. PubMed ID: 846681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS; Johnson CA; Kotchen JM; Kotchen TA
    Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 11. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
    J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
    [No Abstract]   [Full Text] [Related]  

  • 12. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
    Adlin EV; Marks AD; Channick BJ
    Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary hypertension with low plasma renin level].
    Klaus D; Klumpp F; Zehner J
    Dtsch Med Wochenschr; 1973 Oct; 98(42):1980-7. PubMed ID: 4591648
    [No Abstract]   [Full Text] [Related]  

  • 18. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.
    Carey RM; Douglas JG; Schweikert JR; Liddle GW
    Arch Intern Med; 1972 Dec; 130(6):849-54. PubMed ID: 5082464
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
    Thomas GW; Ledingham JG; Beilin LJ; Yeates KM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.